About Us

Professor Yi Lu, Co-Founder

Yi LuProf. Yi Lu is the Founder and scientific advisor of GlucoSentient. He is the Jay and Ann Schenck Professor in the Departments of Chemistry, Biochemistry, Materials Science and Engineering and Bioengineering. He is also a member of the Center for Biophysics and Computational Biology and Beckman Institute for Advanced Science and Technology. His research interests lie at the interface between chemistry and biology. Dr. Lu has received numerous research and teaching awards, including the Fellow of the American Association for the Advancement of Science (2007), Early Career Award, Society of Biological Inorganic Chemistry (2007), Howard Hughes Medical Institute Professor Award (2002), Camile Dreyfus Teacher-Scholar Award (1999), Alfred P. Sloan Research Fellowship (1998), Research Corporation Cottrell Scholars Award (1997), and the Beckman Young Investigators Award (1996). Dr. Lu is an accomplished entrepreneur, holding more than 20 US and international patents, and founder of ANDalyze.


Steve Mayer, M.D., Acting CEO/CMO

Dr. Steve Mayer joins GlucoSentient with over twenty-five years of diverse experience in the diagnostics, device and pharmaceutical industry with a Medical Doctor (MD) and a BS degree with honors in Chemical Engineering, both from University of Wisconsin-Madison. Previously, he was a senior scientist and program manager at Abbot Diagnostic Division (ADD) with expertise in self-performing immunoassays for the consumer. Additionally, Dr. Mayer also designed, invented and fabricated Qwikwash: a commercially successful enzyme immunoassay bead washing system and diagnostic disposables for Abbott Laboratories and provided design services for high volume automated hospital and blood bank immunoassay analyzers.

After 20 years at Abbott, Dr. Mayer resigned in 2002 and has since been a board director, scientific consultant and advisor for several diagnostic, device and pharmaceutical companies. He has been a board director for Organ Recovery Systems since 2003 and has been instrumental in leading the company through an IPO, maintaining scientific leadership in transplant medicine and building a profitable company with a strong product pipeline.

Tian Lan, Ph.D., CTO/Co-founder
Yi Lu Dr. Tian Lan obtained his Ph.D. at the University of Illinois Urbana Champaign with Professor Lu’s and recently joined GlucoSentient. His current role is leading the technical team toward GlucoSentient assay development. He graduated from the University of Oregon with a B.S in Biochemistry with department honor. Later, he joined Professor Yi Lu’s research group at UIUC as a graduate student. He has expertise in the isolation, characterization and application of functional DNAs and worked extensively on isolation of functional DNAs for several targets, such as aptamer on melamine, perchlorate and Cd2+ selective DNAzyme. Besides the expertise on functional DNAs, he also has a broad knowledge in nanomaterials for sensing applications. One of the sensors he discovered is currently utilized by ANDalyze Inc. for environmental monitoring of heavy metal ions. In addition, as a senior graduate student in the laboratory, he lead a group of graduate students and post-doctoral researchers to solve the three-dimensional structure of DNAzymes.

Brian (Ngo Yin) Wong, Ph.D., Advisor/Co-founder

Chris Sorensen, Advisor